NeurOp has signed an option agreement with Seyltx involving novel GluN2B inhibitors developed by NeurOp.
NeurOp honored at Georgia Life Sciences Summit
NeurOp was selected as one of the top three startups at the Georgia Life Sciences Summit Company Showcase in 2024.
NeurOp Selected to Compete in Innovation Challenge at RESI 2017
NeurOp, Inc. is one of 40 companies selected from a pool of over 100 applicants to compete in the Life Science Nation’s RESI Innovation Challenge on Sept. 26, 2017 in Boston. Companies will compete on scientific merit and investment potential.
Redefining Early-Stage Investments (RESI) Innovation Challenge
September 26, 2017
Marriott Copley Place | Boston
Biotech Showcase 2016 | San Francisco
NeurOp will present at the 8th Annual Biotech Showcase 2016 in San Francisco, CA to be held January 11-13th. Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives at one of the industry’s largest annual healthcare investor conferences.
Tuesday, January 12, 2016
9:30 am PT
Track: A – Hearst
Biotech Showcase 2016
Parc 55 San Francisco – Union Square
55 Cyril Magnin St., 4th Floor
San Francisco, CA 94102
Life Sciences Summit | New York City – Dec. 2015
NeurOp will present at the upcoming Life Sciences Summit on December 2, 2015 at 2:15pm ET. This two-day program features corporate presentations by promising young companies with transformative science that targets unmet medical needs.
Life Sciences Summit
Dec. 1-2, 2015
10 on the Park at Time Warner Center
60 Columbus Circle
10th Floor
New York, New York 10019